CCK₂ Receptor-Targeted PET/CT in Medullary Thyroid Cancer Using [⁶⁸Ga]Ga-DOTA-CCK-66

J Nucl Med. 2024 Mar 1;65(3):493-494. doi: 10.2967/jnumed.123.266380.

Affiliations

¹ Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany; and.
² Department of Chemistry, Chair of Pharmaceutical Radiochemistry, TUM School of Natural Sciences, Technical University of Munich, Garching, Germany.
³ Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany; and constantin.lapa@uk-augsburg.de.

PMID: 37918864
DOI: 10.2967/jnumed.123.266380

No abstract available

MeSH terms

Carcinoma, Neuroendocrine* / diagnostic imaging
Gallium Radioisotopes
Heterocyclic Compounds, 1-Ring*
Humans
Positron Emission Tomography Computed Tomography
Thyroid Neoplasms* / diagnostic imaging

Substances

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Gallium Radioisotopes
Heterocyclic Compounds, 1-Ring

Supplementary concepts

Thyroid cancer, medullary